ANTONIO CUBANO: Open Payments
NPI 1881895951 · DEBARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 63 payments from 16 companies in 2025. Trend: 2023 $412 · 2024 $1,109 · 2025 $1,355
Food & beverage: $1,355
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $205 |
| ABBVIE INC. | 9 | $174 |
| E.R. Squibb & Sons, L.L.C. | 6 | $144 |
| Janssen Pharmaceuticals, Inc | 8 | $139 |
| Axsome Therapeutics, Inc. | 4 | $136 |
| Neurocrine BioSciences, Inc. | 4 | $102 |
| Teva Pharmaceuticals USA, Inc. | 5 | $94 |
| Alkermes, Inc. | 3 | $83 |
| Lundbeck LLC | 3 | $72 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $50 |
Products named: REXULTI, VRAYLAR, COBENFY, Auvelity, SPRAVATO, INGREZZA, AUSTEDO XR, LYBALVI.
Industry payments across FL — which companies pay providers there.
